Role of adhesion mechanisms in the pathogenesis of chronic synovitis

British Journal of Rheumatology

Volumn 35, Issue 12, 1996, Pages 1198-1215

  Pitzalis, C ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Adhesion; CD45R0; Migration; Pathogenesis; Rheumatoid arthritis; Synovitis; T lymphocytes

Indexed keywords

CD45 ANTIGEN;

ARTHROPATHY; ARTICLE; BULLOUS SKIN DISEASE; CELL ADHESION; CELL MIGRATION; DELAYED HYPERSENSITIVITY; EFFECTOR CELL; ENDOTHELIUM; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; EXTRAVASATION; HUMAN; INFLAMMATION; JOINT; LYMPHOCYTE; MEMORY CELL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVITIS; T LYMPHOCYTE; UMBILICAL VEIN; CHRONIC DISEASE; CYTOLOGY; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ARTHRITIS, RHEUMATOID; CELL ADHESION; CHRONIC DISEASE; HUMANS; SYNOVITIS; T-LYMPHOCYTES;

EID: 0030465593     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (108)

1. Pitzalis C, Kingsley G, Murphy J, Panayi G. Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid joint. Clin Immunol Immunopathol 1987;45:252-8.
2. Kingsley G, Pitzalis C, Kyriazis N, Panayi GS. Abnormal helper-inducer/suppressor-inducer T-cell subset distribution and T-cell activation status are common to all types of chronic synovitis. Scand J Immunol 1988;28:225-32.
3. Pitzalis C, Kingsley G, Haskard D, Panayi G. The preferential accumulation of helper-inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion. Eur J Immunol 1988;18:1397-404.
4. Pitzalis C, Kingsley GH, Covelli M, Meliconi R, Markey A, Panayi GS. Selective migration of the human helper-inducer memory T cell subset: confirmation by in vivo cellular kinetic studies. Eur J Immunol 1991;21:369-76.
5. Pitzalis C, Cauli A, Pipitone N et al. Preferential migration of CLA positive T lymphocytes to the skin but not to the joint in psoriatic arthritis. Arthritis Rheum 1996;39:137-45.
6. Rodriguez RM, Pitzalis C, Kingsley GH, Henderson E, Humphries MJ. T lymphocyte adhesion to fibronectin (FN): a possible mechanisrn for T cell accumulation in the rheumatoid joint. Clin Exp Immunol 1992;89:439-45.
7. Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 1990;33:768-73.
8. Panayi GS, Lanchbury JS, Kingsley GH. The importance of the T-cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992;35:729-35.
9. Kingsley G, Pitzalis C, Panayi GS. Immunogenetic and cellular immune mechanisms in rheumatoid arthritis: relevance to new therapeutic strategies. [Review] Br J Rheumatol 1990;29:58-64.
10. Lanchbury JS, Pitzalis C. Cellular immune mechanisms in rheumatoid arthritis and other inflammatory arthritides. [Review] Curr Opin Immunol 1993;5: 918-24.
11. Chattopadhyay C, Chattopadhyay H, Natvig JB, Michaelsen TE, Mellbye OJ. Lack of suppressor cell activity in rheumatoid synovial lymphocytes. Scand J Immunol 1979;10:309-16.
12. Morimoto C, Letvin NL, Diastaso JA, Aldrich WR, Schlossman SF. The isolation and characterisation of the human suppressor-inducer T cell subset. J Immunol 1985;134:1508-15.
13. Smith SH, Brown MH, Rowe D, Callard RE, Beverley PCL. Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1. Immunology 1986;58:63-70.
14. Morimoto C, Letvin NL, Boyd AW et al. The isolation and characterisation of the human helper-inducer T cell subset. J Immunol 1985;134:3762-9.
15. Emery P, Gentry KC, Mackay IR, Muirden KD, Rowley M. Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis. Arthritis Rheum 1987;30:849-56.
16. Bergoth V, Kontinnen YT, Nykanen P, Von Essen R, Koota K. Proliferating cells in the synovial fluid in rheumatic disease. An analysis with autoradiography-immunoperoxidase double staining. Scand J Immunol 1985;22:383-8.
17. Bonvoisin B, Cordier G, Revillard JP, Lejeunne E, Bouvier M. Increased DNA and/or RNA content of synovial fluid cells in rheumatoid arthritis: a flow-cytometry study. Ann Rheum Dis 1984;43:222-7.
18. Kontinnen YT, Bergroth V, Nykanen P. Lymphocyte activation in rheumatoid arthritis synovial fluid in vivo. Scand J Immunol 1985;22:503-7.
19. Hemler ME, Glass D, Coblyn JS, Jacobson JG. Very late activation antigens on rheumatoid synovial fluid T lymphocytes - association with stages of T cell activation. J Clin Invest 1986;78:696-702.
20. Serra HM, Krowa JF, Ledbetter JQ, Pilarski LM. Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event. J Immunol 1988;140:1435-41.
21. Akbar AN, Timms A, Janossy G. Cellular events during memory T-cell activation in vitro: the UCHL1 (180,000 MW) determinant is newly synthesized after mitosis. Immunology 1989;66:213-8.
22. Akbar AN, Terry L, Timms A, Beverley PC, Janossy G. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol 1988;140:2171-8.
23. Beverley PC, Daser A, Michie CA, Wallace DL. Functional subsets of T cells defined by isoforms of CD45. [Review] Biochem Soc Trans 1992;20:184-7.
24. Bell EB. Function of CD4 T cell subsets in vivo: expression of CD45R isoforms. [Review] Semin Immunol 1992;4:43-50.
25. Stewart BW. Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. [Review] J Natl Cancer Inst 1994;86:1286-96.
26. Krammer PH, Behrmann I, Daniel P, Dhein J, Debatin KM. Regulation of apoptosis in the immune system. [Review] Curr Opin Immunol 1994;6:279-89.
27. Williams GT, Smith CA. Molecular regulation of apoptosis: genetic controls on cell death. [Review] Cell 1993;74:777-9.
28. Akbar AN, Salmon M, Savill J, Janossy G. A possible role for bcl-2 in regulating T-cell memory - a 'balancing act' between cell death and survival. [Review] Immunol Today 1993;14:526-32.
29. Carson DA, Ribeiro JM. Apoptosis and disease. [Review] Lancet 1993;341:1251-4.
30. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. [Review] Cell 1991;67:1033-6.
31. Shimizu Y, Newman W, Tanaka Y, Shaw S. Lymphocyte interactions with endothelial cells. [Review] Immunol Today 1992;13:106-12.
32. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. [Review] Cell 1994;76:301-14.
33. Adams DH, Shaw S. Leucocyte-endothelial integrations and regulation of leucocyte migration [see comments]. [Review] Lancet 1994;343:831-6.
34. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991;65:859-73.
35. Lasky LA. Selectins: interpreters of cell-specific carbohydrate information during inflammation. [Review] Science 1992;258:964-9.
36. Bevilacqua MP, Nelson RM. Selectins. [Review] J Clin Invest 1993;91:379-87.
37. Kelvin DJ, Michiel DF, Johnston JA et al. Chemokines and serpentines: the molecular biology of chemokine receptors. [Review] J Leukocyte Biol 1993;54:604-12.
38. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 1994;6:865-73.
39. Hogg N, Landis RC. Adhesion molecules in cell interactions. [Review] Curr Opin Immunol 1993;5:383-90.
40. Hogg N, Harvey J, Cabanas C, Landis RC. Control of leukocyte integrin activation. [Review] Am Rev Respir Dis 1993;148:S55-9.
41. Gowans JL, Knight EJ. The route of recirculation of lymphocytes in the rat. Proc R Soc London Biol Sci 1964;159:257.
42. Marchesi VT, Gowans JL. The migration of lymphocytes through the endothelium of venules in lymph nodes. Proc R Soc London Biol Sci 1964;159:283.
43. Freemont AJ, Jones CJ, Bromley M, Andrews P. Changes in vascular endothelium related to lymphocyte collections in diseased synovia. Arthritis Rheum 1983;26:1427-33.
44. Freemont AJ. Functional and biosynthetic changes in endothelial cells of vessels in chronically inflamed tissues: evidence for endothelial control of lymphocyte entry into diseased tissues. J Pathol 1988;155: 225-30.
45. Yanni G, Whelan A, Feighery C, Fitzgerald O, Bresnihan B. Morphometric analysis of synovial membrane blood vessels in rheumatoid arthritis: associations with the immunohistologic features, synovial fluid cytokine levels and the clinical course. J Rheumatol 1993;20:634-8.
46. van Dinther-Janssen AC, Pals ST, Scheper R, Breedveld F, Meijer CJ. Dendritic cells and high endothelial venules in the rheumatoid synovial membrane. J Rheumatol 1990;17:11-7.
47. Yu CL, Haskard DO, Cavender D, Johnson AR, Ziff M. Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin Exp Immunol 1985;62:554-60.
48. Cavender DE, Haskard DO, Joseph B, Ziff MA. Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol 1986;136:203-7.
49. Hughes CC, Male DK, Lantos PL. Adhesion of lymphocytes to cerebral microvascular cells: effects of interferon-gamma, tumour necrosis factor and interleukin-1. Immunology 1988;64:677-81.
50. Miossec P, Yu C-L, Ziff MA. Lymphocyte chemotactic activity of human interleukin-1. J Immunol 1986;133: 2007-11.
51. Hay JB, Hobbs BB, Johnston MG, Movat HZ. The role of hyperemia in cellular hypersensitivity reactions. Int Arch Allergy Appl Immunol 1977;55:324-31.
52. Hay JB, Johnston MG, Vadas P, Chin W, Issekutz T, Movat HZ. Relationships between changes in blood flow and lymphocyte migration induced by antigen. [Review] Monogr Allergy 1980;16:112-25.
53. Hale LP, Martin ME, McCollum DE et al. Immunohistologic analysis of the distribution of cell adhesion molecules within the inflammatory synovial microenvironment. Arthritis Rheum 1989;32:22-30.
54. Berlin C, Bargatze RF, Campbell JJ et al. alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 1995;80:413-22.
55. Kingsley GH, Panayi GS. Mechanism of the deficient mononuclear cell response to tuberculin PPD in rheumatoid arthritis. Clin Rheumatol 1986;5:149-53.
56. Yanni G, Whelan A, Feighery C, Bresnihan B. Analysis of cell populations in rheumatoid arthritis synovial tissues. Semin Arthritis Rheum 1992;21:393-9.
57. Mackay CR, Marston WL, Dudler L, Spertini O, Tedder TF, Hein WR. Tissue-specific migration pathways by phenotypically distinct subpopulations of memory T cells. Eur J Immunol 1992;22:887-95.
58. Mackay CR. Homing of naive, memory and effector lymphocytes. [Review] Curr Opin Immunol 1993;5: 423-7.
59. Picker LJ, Butcher EC. Physiological and molecular mechanisms of lymphocyte homing. [Review] Annu Rev Immunol 1992;10:561-91.
60. Picker LJ. Mechanisms of lymphocyte homing. [Review] Curr Opin Immunol 1992;4:277-86.
61. Butcher EC. Leukocyte-endothelial cell adhesion as an active, multi-step process: a combinatorial mechanism for specificity and diversity in leukocyte targeting. [Review] Adv Exp Med Biol 1992;323:181-94.
62. Michie SA, Streeter PR, Bolt PA, Butcher EC, Picker LJ. The human peripheral lymph node vascular addressin. An inducible endothelial antigen involved in lymphocyte homing. Am J Pathol 1993;143:1688-98.
63. Berlin C, Berg EL, Briskin MJ et al. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993;74:185.
64. Rose ML, Parrott DMV, Bruce RG. The accumulation of immunoblasts in extravascular tissues including mammary gland, peritoneal cavity, gut and skin. Immunology 1978;35:415-23.
65. Issekutz TB, Chin W, Hay JB. The characterization of lymphocytes migrating through chronically inflamed tissues. Immunology 1982;46:59-66.
66. Jalkanen S, Steere AC, Fox RI, Butcher EC. A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science 1986;233:556-8.
67. Lazarovits AI, Karsh J. Differential expression in rheumatoid synovium and synovial fluid of alpha 4 beta 7 integrin. A novel receptor for fibronectin and vascular cell adhesion molecule-1. J Immunol 1993;151:6482-9.
68. Schweighoffer T, Tanaka Y, Tidswell M et al. Selective expression of integrin alpha 4 beta 7 on a subset of human CD4+ memory T cells with hallmarks of gut-trophism. J Immunol 1993;151:717-29.
69. Picker LJ, Michie SA, Rott LS, Butcher EC. A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 1990;136:1053-68.
70. Koszik F, Strunk D, Simonitsch I, Picker LJ, Stingl G, Payer E. Expression of monoclonal antibody HECA-452-defined E-selectin ligands on Langerhans cells in normal and diseased skin. J Invest Dermatol 1994;102:773-80.
71. Berg EL, Yoshino T, Rott LS et al. The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J Exp Med 1991;174:1461-6.
72. De Boer OJ, Horst E, Pals ST, Bos JD, Das PK. Functional evidence that the HECA-452 antigen is involved in the adhesion of human neutrophils and lymphocytes to tumour necrosis factor-alpha-stimulated endothelial cells. Immunology 1994;81:359-65.
73. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Bergstresser PR. Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. J Immunol 1993;150:1122-36.
74. Markey AC, Allen MH, Pitzalis C, MacDonald DM. T-cell inducer populations in cutaneous inflammation: a predominance of T helper-inducer lymphocytes (THi) in the infiltrate of inflammatory dermatoses. Br J Dermatol 1990;122:325-32.
75. Picker LJ. Control of lymphocyte homing. [Review] Curr Opin Immunol 1994;6:394-406.
76. Ruoslahti E. Fibronectin and its receptors. [Review] Annu Rev Biochem 1988;57:375-413.
77. Hynes RO. Integrins: a family of cell surface receptors. [Review] Cell 1987;48:549-54.
78. Paul JI, Schwarzbauer JE, Tamkun JW, Hynes RO. Cell-type-specific fibronectin subunits generated by alternative splicing. J Biol Chem 1986;261:12258-65.
79. Mould AP, Wheldon LA, Komoriya A, Wayner EA, Yamada KM, Humphries MJ. Affinity chromatographic isolation of the melanoma adhesion receptor for the IIICS region of fibronectin and its identification as the integrin alpha 4 beta 1. J Biol Chem 1990; 265:4020-4.
80. Wayner EA, Garcia-Pardo A, Humphries MJ, McDonald JA, Carter WG. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol 1989;109:1321-30.
81. Garcia-Pardo A, Ferreira OC. Adhesion of human T-lymphoid cells to fibronectin is mediated by two different fibronectin domains. Immunology 1990;69:121-6.
82. Takada Y, Huang C, Hemler ME. Fibronectin receptor structures in the VLA family of heterodimers. Nature 1987;326:607-9.
83. Humphries MJ, Akiyama SK, Komoriya A, Olden K, Yamada KM. Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion. J Cell Biol 1986;103:2637-47.
84. Humphries MJ, Komoriya A, Akiyama SK, Olden K, Yamada KM. Identification of two distinct regions of the type III connecting segment of human plasma fibronectin that promote cell type-specific adhesion. J Biol Chem 1987;262:6886-92.
85. Pierschbacher MD, Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984;309: 30-3.
86. Nojima Y, Humphries MJ, Mould AP et al. VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS1 alternatively spliced domain of fibronectin. J Exp Med 1990;172:1185-92.
87. Pulido R, Elices MJ, Campanero MR et al. Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. Correlation with distinct alpha 4 epitopes. J Biol Chem 1991;266:10241-5.
88. Elices MJ, Osborn L, Takada Y et al. VCAM-1 on activated endothelium interacts with the leucocyte integrin VLA-4 at a site distinct from the VLA-4/ fibronectin site. Cell 1990;60:577-84.
89. van Dinther-Janssen AC, Pals ST, Scheper RJ, Meijer CJ. Role of the CS1 adhesion motif of fibronectin in T cell adhesion to synovial membrane and peripheral lymph node endothelium. Ann Rheum Dis 1993;52:672-6.
90. Elices MJ, Tsai V, Strahl D et al. Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J Clin Invest 1994;93:405-16.
91. Gailit J, Ruoslahti E. Regulation of the fibronectin receptor affinity by divalent cations. J Biol Chem 1988;263:12927-32.
92. Dransfield I, Cabanas C, Craig A, Hogg N. Divalent cation regulation of the function of the leukocyte integrin LFA-1. J Cell Biol 1992;116:219-26.
93. Pitzalis C, Kingsley G, Lanchbury JS, Murphy J, Panayi GS. Expression of HLA-DR, DQ and DP antigens and interleukin-2 receptor on synovial fluid T lymphocyte subsets in rheumatoid arthritis: evidence for 'frustrated' activation. J Rheumatol 1987; 14:662-6.
94. Shimizu Y, van Seventer GA, Horgan KJ, Shaw S. Regulated expression and binding of three VLA (beta 1) integrin receptors on T cells. Nature 1990;345:250-3.
95. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-9.
96. Kornberg L, Earp HS, Parsons JT, Schaller M, Juliano RL. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem 1992;267:23439-42.
97. Matsuyama T, Yamada A, Kay J, Yamada KM, Akiyama SK, Schlossman SF. Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex. J Exp Med 1989;170:1133-48.
98. Shimizu Y, van Seventer GA, Horgan KJ, Shaw S. Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin. J Immunol 1990;145:59-67.
99. Yamada A, Nikaido T, Nojima Y, Schlossman SF, Morimoto C. Activation of human CD4 T lymphocytes. Interaction of fibronectin with VLA-5 receptor on CD4 cells induces the AP-1 transcription factor. J Immunol 1991;146:53-6.
100. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 1992;255:1125-7.
101. Ma XL, Lefer DJ, Lefer AM, Rothlein R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 1992;86:937-46.
102. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992;356: 63-6.
103. Mulligan MS, Paulson JC, De Frees S, Zheng ZL, Lowe JB, Ward PA. Protective effects of oligosaccharides in P-selectin-dependent lung injury. Nature 1993;364:149-51.
104. Mulligan MS, Lowe JB, Larsen RD et al. Protective effects of sialylated oligosaccharides in immune complex-induced acute lung injury. J Exp Med 1993;178:623-31.
105. Martin S, Casasnovas JM, Staunton DE, Springer TA. Efficient neutralization and disruption of rhinovirus by chimeric ICAM-1/immunoglobulin molecules. J Virol 1993;67:3561-8.
106. Jasin HE, Lightfoot E, Davis LS, Rothlein R, Faanes RB, Lipsky PE. Amelioration of antigen-induced arthritis in rabbits treated with monoclonal antibodies to leukocyte adhesion molecules. Arthritis Rheum 1992;35:541-9.
107. Barbadillo C, Andreu JL, Mulero J, Sanchez-Madrid F. Anti-VLA4 mAb prevents adjuvant arthritis in Lewis rats. Arthritis Rheum 1993;36:S95.
108. Kavanaugh AF, Davis LS, Nichols LA, Norris SH, Rothlein R, Lipsky PE. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum 1994;37:992-9.